A new approach promises rapid relief—but is faster really better? Here’s what experts say.

In NSCLC, ATNM-400 demonstrated antitumor activity as monotherapy and enhanced activity in combination with KRAS or ALK inhibitors, including in resistant models. These findings extend earlier ...

The Guardians host the Rays in ALCS Game 4 with a 2-1 series lead and are priced as a near pick'em. Here are the best prices ...

Opinion covers children 2+ with open growth plates. Final EU decision is expected in Q4 2026; Ascendis expects German launch ...